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Abstract: The trichothecene mycotoxin deoxynivalenol (DON) is commonly encountered 
in human cereal foods throughout the world as a result of infestation of grains in the field 
and in storage by the fungus Fusarium. Significant questions remain regarding the risks 
posed to humans from acute and chronic DON ingestion, and how to manage these risks 
without imperiling access to nutritionally important food commodities. Modulation of the 
innate immune system appears particularly critical to DON’s toxic effects. Specifically, 
DON induces activation of mitogen-activated protein kinases (MAPKs) in macrophages 
and monocytes, which mediate robust induction of proinflammatory gene expression—
effects  that  can  be  recapitulated  in  intact  animals.  The  initiating  mechanisms  for  
DON-induced ribotoxic stress response appear to involve the (1) activation of constitutive 
protein kinases on the damaged ribosome and (2) autophagy of the chaperone GRP78 with 
consequent  activation  of  the  ER  stress  response.  Pathological  sequelae  resulting  from 
chronic  low  dose  exposure  include  anorexia,  impaired  weight  gain,  growth  hormone 
dysregulation  and  aberrant  IgA  production  whereas  acute  high  dose  exposure  evokes 
gastroenteritis, emesis and a shock-like syndrome. Taken together, the capacity of DON to 
evoke ribotoxic stress in mononuclear phagocytes contributes significantly to its acute and 
chronic  toxic  effects  in  vivo.  It  is  anticipated  that  these  investigations  will  enable  the 
identification  of  robust  biomarkers  of  effect  that  will  be  applicable  to  epidemiological 
studies of the human health effects of this common mycotoxin. 
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1. Introduction 
Consumption of bread  made  from overwintered cereal grains infested with the mold Fusarium 
during World War II in the USSR resulted in massive outbreaks of alimentary toxic aleukia (ATA) [1]. 
ATA, a frequently fatal disease, involves both the immune and gastrointestinal systems and, as its 
name implies, evokes symptoms that included diarrhea, vomiting, leukopenia, hemorrhage and shock. 
Human gastroenteritis with nausea, diarrhea and vomiting as primary symptoms has been similarly 
linked to Fusarium-contaminated foods in Japan, Korea [2], China [3] and India [4]. Retrospective 
studies have demonstrated that a commonality among the fusaria isolated from such outbreaks is their 
capacity to produce a class of highly toxic secondary metabolites known as trichothecenes. 
Trichothecene mycotoxins are low molecular weight (≈200–500 D) sesquiterpenoids that contain 
both a common 9, 10 double bond and 12, 13 epoxide group as well as varied substituent groups that 
contribute significantly to their toxic potential. Of the over 200 members of this intriguing family that 
have  been  so  far  described  [5–7],  deoxynivalenol  (DON)  is  very  commonly  encountered  in 
cereal-based foods throughout the world [8]. High dose, acute exposure of sensitive animal species to 
DON, most notably pigs (e.g., 15–20 ppm in diet), elicits abdominal distress, increased salivation, 
malaise,  diarrhea  and  emesis  [9–14].  Contrastingly,  prolonged  low  dose  feeding  of  DON  to 
experimental  pigs  and  mice  (e.g.,  1–10  ppm)  impairs  weight  gain,  causes  anorexia  and  possibly 
interferes with nutritional efficiency [13]. DON can stimulate or suppress immune function depending 
on dose, exposure frequency, timing and the functional immune assay being used [15]. As will be 
discussed below, this diverse spectrum of effects is likely to result from differences in intensity and 
duration of kinase signaling and the extent of resultant gene expression. 
Large-scale epidemics of Fusarium infection in wheat, barley and corn with corresponding DON 
contamination are increasingly being observed in the U.S. and other parts of the world, possibly as 
inadvertent outcomes of expanded use of ―no-till farming‖, inappropriate crop rotation and climate 
change. Recent biomarker studies indicate that most persons who consume wheat-containing foods are 
regularly  exposed  to  DON  [16,17].  Not  surprisingly,  there  is  growing  global  concern  over  the 
possibility of adverse human health outcomes resulting from acute and chronic DON consumption. 
Understanding the mode of action of natural toxins such as DON facilitates accurate prediction of 
potential toxic effects, thereby enabling more precise science-based risk assessment and risk management. 
Studies in our laboratory and others have revealed that the innate immune system plays an intricate 
role in DON toxicity. The purpose of this review is to discuss (1) the molecular mechanisms that 
underlie  DON  toxicity  with  a  specific  focus  on  mononuclear  phagocytes  and  (2)  the  relationship 
between DON-induced proinflammatory gene expression and downstream pathologic sequelae. Toxins 2010, 2                             
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2. DON Targets Mononuclear Phagocytes 
2.1. In vitro effects of DON 
Primary cultures and cell lines derived from bone marrow, gut epithelium, liver, lymphoid tissue, 
kidney, lung and various cancers have been employed to assess DON’s toxic effects. Leukocytes, most 
notably those of mononuclear phagocyte lineage, appear to be particularly responsive to DON [15]. 
Exposure of macrophages and monocytes to DON at low or moderate concentrations (i.e., partially 
inhibit translation) will selectively induce proinflammatory gene expression, but extended exposures to 
high  concentrations  (i.e.,  completely  inhibit  translation)  can  cause  cell  death.  Susceptibility  to 
apoptosis  induction  can  vary  greatly  among  cell  types,  with  primary  cells  sometimes  being  more 
resistant [18]. 
2.2. Mechanisms for DON inhibition of translation 
It has been proposed that trichothecenes including DON inhibit protein synthesis by binding to the 
peptidyl transferase region of the ribosome and interfering with initiation and elongation [19,20]. In 
addition to this canonical mechanism, DON might suppress protein synthesis in at least three other 
ways. For example, incubation of cloned macrophages with DON can result in lesions in the 28s rRNA 
which might render the 60s subunit non-functional [21]. In addition, DON induces activation of a 
ribosome-associated  kinase  known  as  double-stranded  RNA-associated  protein  kinase  (PKR)  [22]. 
Upon activation, PKR can phosphorylate eukaryotic initiation factor 2α (EIF2α), thereby preventing 
translation [23]. Finally, it has recently been observed that DON can upregulate a large number of 
microRNAs  (miRNAs)  associated  with  selective  gene  downregulation  [24].  Since  many  of  these 
DON-induced miRNAs specifically correspond to ribosomal proteins, it is possible that those miRNA 
downregulate  ribosome  synthesis  thus  enabling  DON-exposed  cells  to  economize  and  redistribute 
resources needed for survival. 
2.3. Mechanisms for DON-induced proinflammatory gene upregulation 
Robust upregulation of specific cytokines, chemokines and other inflammation-related proteins by 
DON in vitro is preceded by elevations of their corresponding mRNAs [15] (Table 1). For example, 
DON induces mRNAs for TNF-α and IL-6 in macrophages [25,26], IL-8 in monocytes [27,28] and  
IL-2 expression in T cells [29,30]. The premise that DON and other translational inhibitors selectively 
drive overexpression of specific proteins appears at first to be intuitively contradictory. However, it is 
not  unreasonable  to  predict  that  the  rapid  (e.g.,  1  to  2  h)  and  marked  (e.g.,  10-  to  1000-fold) 
upregulation of selected mRNAs in cells with partially suppressed translation would dramatically skew 
the expressed proteome. This concept is supported by comparable observations made for the ribotoxic 
proteins ricin and Shiga toxin [31–33]. 
Upregulation of mRNA expression by DON involves both transcriptional and post-transcriptional 
processes [15,34–36]. DON induces transcription factor expression (e.g., c-Fos, Fra-2, c-Jun , JunB, 
EGR1,  ATF3)  [37,38]  and  transcription  factor  activation  (e.g.,  NF-κB,  CREB,  AP-1  and  C/EBP) 
[29,39–42].  These  transcription  factors  specifically  regulate  expression  of  inflammation-  and Toxins 2010, 2                             
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immune-related  genes.  DON-induced  transactivation  has  been  confirmed  using  promoter-reporter 
studies assays [28,34,43,44]. 
Table 1. Genes upregulated by deoxynivalenol in mice. 
Gene Family  Gene 
Proinflammatory Cytokines  IL-1α, IL-1β, IL-6, IL-11, TNF-α, TGF-β 
T Cell Cytokines  IFN-γ, IL-2 
Chemokines  MIP-2, MCP-1, Crg-2, CINC-1, MCP-3 
Transcription Factors  cFos, cJun, Fra-2, Jun-B, NR4a1 
Phosphatases  MKP1, CNAb, Ptpn8, Ptprj 
Suppressors of Cytokine Signaling (SOCS)  CIS1,SOCS1, SOCS2 ,SOCS3 
Other  Cox-2, C3aR 
See references [26,34,48,83,100,120]. 
DON also stabilizes mRNAs for TNF-α, IL-6 and COX-2 [25,43,45], and IL-8 [39]. Enhanced 
mRNA stability relates to AUUUA motifs in the 3'-untranslated region (3'-UTR) of mRNAs that target 
transcripts  for  rapid  degradation.  Involvement  of  these  3’  UTRs  has  been  verified  in  studies  of  
DON-induced COX-2 [43] and IL-8 mRNAs [39] stabilization. Notably, mRNA stability in the latter 
investigation was related to translocation of HuR/Elav-like RNA binding protein 1 (ELAVL1) from 
the nucleus to the cytosol and its association with 3'-untranslated region of the IL-8 transcript. 
Transcriptional and post-transcriptional gene upregulation by DON is mediated by mitogen-activated 
protein  kinases  (MAPKs)  known  to  be  critical  for  signal  transduction  in  the  immune  response. 
Activation of  MAPKs  by  translational  inhibitors  was initially  described  in  the landmark  paper  of 
Iordanov et al. [46] who termed it the ―ribotoxic stress response‖. Three MAPK families are activated 
by DON in macrophage and monocyte cultures. These include: extracellular signal regulated protein 
kinase 1 and 2 (ERK1 and 2); (ii) p54 and p46 c-Jun N-terminal kinase 1 and 2 (JNK 1/2) and (iii) p38 [15]. 
While both ERK and p38 contribute to DON-induced transactivation of TNF-α, IL-6 and COX-2, 
only p38 is essential for trichothecene-mediated mRNA stabilization [25,34,43]. Analogous results 
have been observed for IL-8 in U937 human monocytes [47] and primary human mononuclear blood 
cell cultures [48]. Consistent with in vitro studies, DON sequentially induces (1) p38, ERK and JNK 
phosphorylation, (2) activation of the transcription factors AP-1, C/EBP, CREB and NF-κB binding, 
and (3) proinflammatory cytokine mRNA expression in lymphoid tissues of the mouse [49]. 
When specific chemical inhibitors were used to screen for potential upstream kinases that could 
mediate  DON-induced  MAPK  activation,  both  PKR  and  hematopoeitic  cell  kinase  (Hck)  were 
identified as candidate transducers [22,50]. PKR, a widely-expressed serine/threonine protein kinase, 
causes translational inhibition in an evolutionarily conserved antiviral response by phosphorylating 
[23]. PKR functions as a signal integrator for ligand-activated stress-activated protein kinase pathways 
leading to JNK and p38 activation as well as induction of TNF-α, IL-6 and IL-12 expression. Hck, a 
member of the highly conserved Src-family of cytoplasmic
 protein tyrosine kinases, is specifically 
expressed  in  myelomonocytic
 cell  lineages  [51].  Hck  transduces  extracellular
 signals  that  regulate 
critical cellular processes such as proliferation, differentiation, migration and cytokine upregulation 
[52]. PKR and Hck are therefore likely to be essential for early steps in the ribotoxic stress response, Toxins 2010, 2                             
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and,  furthermore,  mediate  initial  events  resulting  in  innate  immune  activation  associated  with 
macrophage exposure to DON (Figure 1). 
Figure 1. DON-induced ribotoxic stress—Mechanism I. One mechanism for DON-induced 
ribotoxic stress is proposed to involve: (1) rapid DON uptake and binding to ribosome;  
(2)  activation  of  ribosomal-associated  PKR  and  Hck;  (3)  interaction  of  p38  with  the 
ribosome; (4) p38 phosphorylation and (5) induction of proinflammatory genes. 
 
2.4. Mechanisms for DON-induced cell death 
MAPK activation also precedes trichothecene-mediated apoptosis in RAW 264.7 macrophage and 
U937 monocyte models suggesting they have an equally important regulatory role in cell death [53]. 
When the contribution of p38 in mediating apoptosis and survival was investigated in DON-treated 
RAW 264.7 macrophages [54], it was observed that at concentrations that inhibit translation partially, 
DON induces p38 and ERK 1/2 phosphorylation within 15 min and this lasts up to 3 h. DON-exposed 
cells exhibit increased caspase 3-dependent DNA fragmentation within 6 h that is suppressed and 
potentiated by p38 inhibition and ERK inhibition, respectively. DON evokes BAX translocation to 
mitochondria and cytochrome C release but does not affect mitochondrial membrane potential. In 
addition, DON also induces p38-dependent p53 activation. The p53 inhibitor PFT and p53 siRNA 
knockdown  suppress  DON-induced  caspase-3  activation  and  consequent  DNA  fragmentation. 
Accordingly,  it  has  been  proposed  that  DON  induces  competing  apoptotic 
(p38→p53→Bax→Mitochondria→Caspase-3) and survival (ERK→AKT/p90Rsk→Bad) pathways in 
RAW 264.7 macrophages. Since both PKR and Hck inhibition suppress DON-induced p53 activation, Toxins 2010, 2                             
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caspase-3  activity  and  apoptosis,  these  kinases  are  also  likely  to  be  upstream  transducers  in  
MAPK-regulated apoptosis [22,42]. 
On a cautionary note, while potent trichothecenes such as T-2 toxin cause robust cell death in 
lymphoid tissues and bone marrow, generally by apoptosis, DON’s effects are more modest [20,53,55–61]. 
Exposure  of  mice  to  25  mg/kg  DON  induces  apoptosis  in  the  thymus,  bone  marrow,  spleen  and 
Peyer’s patches [62], whereas exposure to 12.5 mg/kg does not [63,64] suggesting that relatively high 
DON dose (i.e., 1/2 to 1/3 LD50) is required for this programmed cell death. At 100 to 1000 ng/mL, 
DON induces apoptosis in cloned macrophages and monocytes [22,54,65], T cells [66] and B cells 
[67]. Treatment with DON of thymus, spleen and bone marrow cultures at 250 to 500 ng/mL for 18 h 
induces apoptosis [68], but comparatively higher concentrations of DON (1–50 µ g/mL) are required to 
cause modest apoptosis in T-cells, B-cells and IgA+ cells in mouse lymphoid cultures after 8 h [69]. 
Murine peritoneal macrophages are very resistant to DON even at concentrations up to 5 µg/mL for 
12 h [70]. Comparable variability in DON-induced death induction among hematopoietic precursors 
has been observed [57,71]. Over all, these observations strongly suggest that inherent differences may 
exist in the balance between pro-apoptotic and anti-apoptotic pathways within individual phenotypes. 
Extrapolation  of  apoptosis  studies  conducted  in  cloned  cells,  often  derived  from  tumors,  to  those 
carried out in primary cultures or in intact animals must be therefore performed with caution. 
3. Initiating Events in the Ribotoxic Stress Response 
Although there is recent evidence that DON interacts with both the 40S and 60S ribosomal units 
[72], the specific role of the ribosome in DON-induced MAPK activation and proinflammatory gene 
expression has not been fully delineated. Two possible contributing mechanisms identified to date are 
the direct activation of ribosome-associated kinases (Figure 1) and indirect activation via endoplasmic 
reticulum (ER) stress response (Figure 2). 
It  has  been  increasingly  recognized  that  cells  are  able  to  sense  damage-associated  molecular 
patterns and evoke stress responses as a result [73]. We hypothesized that following DON-mediated 
perturbation or damage to rRNA, the ribosome acts as the initial staging site for MAPKs [74]. 
DON-treated U937 human monocytes and RAW 264.7 murine macrophages ribosomes were therefore 
subjected to sucrose density gradient fractionation and fractions immunoblotted for p38. Both total and 
phosphorylated  p38  were  found  to  increase  in  those  fractions  containing  ribosomal  subunits  and 
monosomes. DON induced a similar segregation of JNK and ERK into the ribosomal fractions with 
concurrent  phosphorylation.  These  data  suggest  that  ribosome  might  serve  as  a  scaffold  in  the 
ribotoxic stress response. It has now been demonstrated that PKR and Hck associate constitutively 
with  ribosomal  fractions  where  they  potentially  integrate  the  initial  ―sensing‖  of  DON-induced 
ribosomal RNA damage and subsequently mediate intracellular kinase signaling [75] (Figure 1). 
DON  and  other  trichothecenes  differ  from  ribosome-inactivating  proteins  (RIPs)  such  as  ricin 
because, being small molecules, they do not possess the inherent enzyme capacity to promote 28S 
rRNA cleavage at the alpha-sarcin/ricin (S/R)-loop (A4256) under cell-free conditions [76]. However, 
incubation of RAW 264.7 cells with either DON or ricin promotes the cleavage of 28S rRNA at two 
other sites (A3560 and A4045) in the peptidyl transferase center. Furthermore, both DON and ricin 
induce RNase activity and RNase L mRNA expression. Toxins 2010, 2                             
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Figure  2.  DON-induced  ribotoxic  stress—Mechanism  II.  The  toxin  increases  unfolded 
protein concentration resulting in sequestering and degradation of GRP78 thereby evoking 
an ER stress. The resultant response includes upregulation of ATF6 and XBP1 resulting in 
CREB  activation.  Another  hypothetical  effect  is  activation  of  ASK1-mediated  p38 
activation (pink shade). Both actions could contribute to proinflammatory gene expression. 
 
Thus, DON can promote intracellular 28S rRNA cleavage, potentially by facilitating the action of 
endogenous RNases and/or by upregulating RNase expression. Although it remains to be resolved 
whether  these  cleavages  are  upstream  or  downstream  to  the  actual  ribotoxic  stress  response,  the 
findings support the possibility that DON interacts with the peptidyl transferase region of the 28S 
rRNA  in  a  similar  fashion  to  ricin.  It  is  tempting  to  speculate  that  DON-induced  perturbation  or 
damage at this site initiates kinase activation and recruitment. PKR is an attractive candidate for the 
sensing role since it has a dsRNA binding site that could bind to damaged rRNA. 
DON interaction with the ribosome also results in an ER stress response (Figure 2). In support of 
this  contention,  DON-treated  macrophages  markedly  decrease  expression  of  cytoplasmic  glucose 
regulated protein (GRP) 78, a chaperone known to mediate ER stress in peritoneal macrophages [18]. 
Since  GRP78  mRNA  is  unchanged  following  DON  treatment,  GRP78  loss  likely  results  from 
degradation  rather  than  reduced  expression.  The  ubiquitin-proteasome  and  autophagy-lysosomal 
pathways  constitute  two  major  avenues  for  protein  degradation  [77].  DON-induced  GRP78 
degradation  is  cathepsin-  and  calpain-dependent  but  not  proteosome-dependent  suggesting  an 
autophagy pathway is involved [18]. Potential mechanisms for DON-induced GRP78 autophagy are 
not  known.  Ribosome  disruption  and/or  translation  arrest  might  cause  accumulation  of  misfolded Toxins 2010, 2                             
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proteins that are sequestered by GRP78. Resultant GRP-containing complexes could enter into the 
autophagy  pathway  and  be  degraded.  It  should  be  noted  that  while  the  autophagy-lysosomal 
predominates here, DON has been demonstrated to upregulate genes associated with regulation and 
structure of the proteosome complex [78] as well as proteins of the ubiquitin-proteosome complex [79]. 
GRP78  regulates  two  transcription  factors,  X-box  binding  protein  1  (XBP1)  and  activating 
transcription factor 6 (ATF6). These bind to cAMP-response element (CRE) and drive expression of 
CRE-dependent genes. DON treatment increases levels of ATF6 as well as IRE1α protein and its 
modified products spliced XBP1 mRNA and XBP1 protein [18]. ATF6 but not XBP1 knockdown 
partially inhibits DON-induced IL-6 expression.  
It is also possible that DON-induced ER stress contributes to MAPK activation. Specifically, it is 
known  that  (1)  IRE  1  activation  mediates  ASK1  phosphorylation  and  (2)  DON  induces  ASK1 
phosphorylation [75]. Accordingly, the ER stress response could thus be a second complementary 
pathway by which DON and other trichothecenes affect innate immune function (Figure 2). Three 
other translation inhibitors, T-2 toxin, Shiga toxin and ricin, also induce GRP78 degradation, further 
suggesting this pathway could be a common mechanism for ribotoxic stress. 
It  should  be  further  noted  that  while  ER  stress  initially  triggers  evolutionarily  conserved  
signal-transduction events designed to ameliorate unfolded protein accumulation in the ER, if these 
events are severe or protracted, they can induce apoptosis. In the future, it will be desirable to identify 
critical events upstream and downstream of GRP degradation as well as ascertain the comparative 
contributions of this pathway to upregulation of inflammatory genes and apoptosis. 
While two possible mechanisms of ribotoxic stress have been proposed here for DON, it does not 
preclude the existence of alternative mechanisms for this or other agents. For example palytoxin does 
not  inhibit  translating  ribosomes  under  cell-free  conditions  but  requires  translating  ribosomes  to 
transduce signals that activate JNKI [81]. Osman et al. [79] observed in a proteomic analysis of EL-4 
thymoma  cells  that  DON  induced  expression  of  My-binding  protein  A  (MYBBP1A).  This  latter 
protein interacts with many ribosomal proteins and can interact with a number of transcription factors [82]. 
4. Pathological Sequelae to DON-Induced Innate Immune Activation 
What is  the in  vivo  relevance  of the  DON-induced proinflammatory  gene  expression?  DON  is 
rapidly distributed throughout the body following oral exposure of mice [83,84] and thus would be 
present in many tissues containing mononuclear phagocytes. Consistent with in vitro studies, DON 
concomitantly induces a wide array of proinflammatory cytokines and chemokines that are detectable 
in spleen, liver, kidney and lung [37,49,84–89]. Ribotoxic stress in mononuclear phagocytes, with 
consequent induction of proinflammatory gene expression, is likely to be critical for the induction of 
acute and chronic sequelae associated with DON poisoning in experimental animals (Figure 3). 
Aberrant elevation of inflammatory mediators, often referred to as a cytokine storm [90], mediate 
the shock-like effects of lipopolysaccharide (LPS) [91] and might likewise contribute to acute toxic 
effects of DON. Indeed, LPS and other toll-like receptor (TLR) agonists potentiate DON toxicity in 
mice [62,89,92–95]. Interestingly, DON has been reported to damage the integrity of intestinal cells 
and allow increased bacterial translocation [96–99]. Such collateral damage could greatly magnify 
DON toxicity. Toxins 2010, 2                             
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Figure  3.  Potential  downstream  pathological  sequelae  associated  with  DON-induced 
ribotoxic stress. 
 
Proinflammatory  cytokines  induce  several  suppressors  of  cytokine  signaling  (SOCS).  DON 
upregulates mRNA expression of four well-characterized SOCS (CIS [cytokine-inducible SH2 domain 
protein],  SOCS1,  SOCS2,  and  SOCS3)  following  cytokine  upregulation  [100].  DON  specifically 
induces SOCS3 mRNAs in muscle, spleen and liver, in addition to CIS1, SOCS1, and SOCS2 in other 
tissues. Notably, hepatic SOCS3 mRNA and protein are sensitive indicators of DON exposure. SOCS 
induction could be an essential feedback mechanism for downscaling proinflammatory gene effects 
and their subsequent pathological sequelae. Another complementary feedback mechanism reported for 
DON is the upregulation of mitogen-activated protein kinase phosphatase 1 [86]. 
Induction of proinflammatory cytokines could contribute DON impairment of appetite and weight 
gain observed by either directly affecting the brain and nervous system [101] and/or SOCS-mediated 
deregulation of growth hormone (GH) signaling [102]. In support of the latter, subchronic dietary 
exposure  of  young  mice  to  DON  decreases  hepatic  insulin-like  growth  factor  acid  labile  subunit 
(IGFALS)  mRNA  expression  and  downregulates  plasma  insulin-like  growth  factor  1  (IGF1)  and 
IGFALS  levels,  as  well  as  attenuates  weight  gain  [103].  Liver  IGFALS  mRNA  levels  decrease 
within 2 h of oral exposure to DON (0.5 to12.5 mg/kg body weight), while 0.1 mg/kg body weight 
DON is without effect. The latter effects co-occur with robust hepatic SOCS3 upregulation with and 
without exogenous GH treatment. Oral DON exposure in the mouse therefore appears to dysregulate 
the GH axis by impairing two critical growth-related proteins, IGFALS and IGF1. While their specific 
contributions to DON-induced food intake and growth retardation still remain to be elucidated, both 
proteins might be useful as serum biomarkers for DON effect [104]. 
Prolonged DON feeding to mice causes dramatic elevations in total serum IgA and serum IgA-immune 
complexes  (IgA-IC)  and  polymeric  IgA  [105,101].  DON-exposed  mice  further  exhibit  kidney 
mesangial IgA accumulation, electron dense mesangial deposits and hematuria [106]—all hallmarks of Toxins 2010, 2                             
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human IgA nephropathy, the most common type of glomerulonephritis worldwide [107]. Following 
removal of DON from mouse diet, toxin-induced elevations in serum IgA, IgA-IC, mesangial IgA and 
hematuria persist for several months [108]. Peyer’s patches (PP) from DON-exposed mice contain 
increased numbers of membrane IgA-bearing cells [109]. PP lymphocytes from PP and spleens of 
DON-fed mice produce significantly more IgA than control cultures prepared from mice fed clean diet 
[110]. Accordingly, in mice exposed to DON, there is rapid polyclonal activation of IgA-secreting 
plasma cells in the gut at the PP level and this is similarly reflected in the systemic compartment. 
DON does not exert adjuvant effects when orally administered with exogenous mucosal antigens, 
but rather, polyclonally induces production of IgAs that are reactive with a variety of intestinal and self 
antigens  [111–114].  Polyspecific,  autoreactive  IgA  may  contribute  to  kidney  immune  complex 
deposition or direct binding to the kidney mesangium. IL-6, which is robustly induced upon DON 
exposure in vivo and ex vivo [87,115] is known to drive differentiation of B cells to IgA production 
[116]. The macrophages appear to contribute to IgA production and IgA nephropathy in DON-exposed 
mice by upregulating IL-6 [117]. Serum IgA, IgA immune complexes, kidney mesangial IgA and 
hematuria  were  significantly  higher  in  DON-fed  wild-type  mice  than  toxin-fed  IL-6  KO  [118] 
suggesting that IL-6 is a requisite cytokine for DON-induced IgA production and resultant IgAN. 
Taken together, DON-induced proinflammatory cytokine production by mononuclear phagocytes in 
vivo is likely to contribute to many pathological sequelae associated with exposure to trichothecene. 
5. Conclusions 
Substantive questions remain regarding the risks posed to humans from acute and chronic DON 
ingestion and how to manage these risks without threatening food security. As demonstrated here, 
DON  dramatically  induces  MAPK  activation  in  vitro  and  in  vivo in  macrophages  and  monocytes 
which in turn, mediate robust induction of both proinflammatory gene expression and, at very high 
doses, apoptosis. Mechanisms for the DON-induced ribotoxic stress response appear to involve the  
(1) activation of constitutive ribosomal kinases and mobilization of MAPKs to the damaged ribosome 
(Figure 1) and (2) autophagy of GRP78 with consequent action of an ER stress response (Figure 2). 
Downstream pathophysiologic sequelae of DON-induced ribotoxic stress in mononuclear phagocytes 
include chronic toxic effects such as anorexia, growth and aberrant IgA production as well as acute 
toxicity  at  high  doses.  It  is  anticipated  that  current  and  future  investigations  will  identify  robust 
biomarkers  of  effect  that  when  coupled  with  biomarkers  of  exposure  [119]  will  facilitate 
epidemiological studies of potential DON-associated human illnesses. 
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